Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Post by Thecook100on Oct 23, 2023 8:06am
129 Views
Post# 35695812

News :)

News :)
 

Datametrex Provides COVID-19 Testing Update

V.DM 

Toronto, Ontario--(Newsfile Corp. - October 23, 2023) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex'') is pleased to announce that it is assessing opportunities to resume its COVID-19 testing business, in response to heightened interest from the film and production industries. The Company previously generated revenues of $25.9mn in 2022, $45.0mn in 2021, and $8.3mn in 2020 from Health Security, with the primary contribution coming from its COVID-19 testing services.

As the world continues to navigate the challenges presented by the COVID-19 pandemic, the film and production industry has shown a growing need for reliable and efficient testing solutions to ensure the safety of their staff and the successful execution of their projects.

The Public Health Agency of Canada reports that COVID-19 hospitalizations are on the rise across Canada as a wave of infections sweeps the population and COVID-19 hospitalizations have reached numbers not seen since last winter. (Source: https://www.ctvnews.ca/health/coronavirus/covid-19-hospitalizations-reach-numbers-not-seen-since-last-winter-1.6605491)

With the recent resurgence of COVID-19 cases, the Company recognizes that COVID-19 testing services may be essential for the film and production industry to implement rigorous safety measures on set and are closely monitoring the regulatory updates and guidelines related to COVID-19 testing within the film and production industry. The Company is now actively evaluating the possibility of reinstating its COVID-19 testing services, aligning with industry-specific regulations, and ensuring that the highest safety standards are upheld.

As discussions continue, Datametrex remains dedicated to exploring the potential of providing COVID-19 testing services to the film and production industry and contributing to the safety and well-being of all involved in these projects.

"We are pleased to see the film and production industry express interest in our COVID-19 testing services. The safety and well-being of individuals working on set are paramount, and we are committed to offering reliable testing solutions to help the industry maintain a safe and productive environment," said Marshall Gunter, Chief Executive Officer of the Company


 

Datametrex Provides COVID-19 Testing Update

V.DM 

Toronto, Ontario--(Newsfile Corp. - October 23, 2023) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex'') is pleased to announce that it is assessing opportunities to resume its COVID-19 testing business, in response to heightened interest from the film and production industries. The Company previously generated revenues of $25.9mn in 2022, $45.0mn in 2021, and $8.3mn in 2020 from Health Security, with the primary contribution coming from its COVID-19 testing services.

As the world continues to navigate the challenges presented by the COVID-19 pandemic, the film and production industry has shown a growing need for reliable and efficient testing solutions to ensure the safety of their staff and the successful execution of their projects.

The Public Health Agency of Canada reports that COVID-19 hospitalizations are on the rise across Canada as a wave of infections sweeps the population and COVID-19 hospitalizations have reached numbers not seen since last winter. (Source: https://www.ctvnews.ca/health/coronavirus/covid-19-hospitalizations-reach-numbers-not-seen-since-last-winter-1.6605491)

With the recent resurgence of COVID-19 cases, the Company recognizes that COVID-19 testing services may be essential for the film and production industry to implement rigorous safety measures on set and are closely monitoring the regulatory updates and guidelines related to COVID-19 testing within the film and production industry. The Company is now actively evaluating the possibility of reinstating its COVID-19 testing services, aligning with industry-specific regulations, and ensuring that the highest safety standards are upheld.

As discussions continue, Datametrex remains dedicated to exploring the potential of providing COVID-19 testing services to the film and production industry and contributing to the safety and well-being of all involved in these projects.

"We are pleased to see the film and production industry express interest in our COVID-19 testing services. The safety and well-being of individuals working on set are paramount, and we are committed to offering reliable testing solutions to help the industry maintain a safe and productive environment," said Marshall Gunter, Chief Executive Officer of the Company


<< Previous
Bullboard Posts
Next >>